Home > PS Ratio > AJANTA PHARMA

AJANTA PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of AJANTA PHARMA is 7.28.

Share Price ₹2,800.7Jul 30,2025
Market Cap ₹34,980.1 Cr
Sales-TTM₹4,805.8 CrTTM-Consolidated Results
Price/Sales7.28xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AJANTA PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AJANTA PHARMA is calculated as :

Current Market Cap [ ₹34,980.1 Cr] as on Jul 30,2025

(/) Sales [ ₹4,805.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 7.28x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AJANTA PHARMA , the investors are currently willing to pay '7.28 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AJANTA PHARMA !

The chart below summarizes the trend in P/S Ratio of AJANTA PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of AJANTA PHARMA


PS Ratio Performance Analysis for AJANTA PHARMA

- AJANTA PHARMA 's latest p/e ratio is 7.28x.

- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.56x.

- AJANTA PHARMA 's operated at median p/e ratio of 5.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2025 at 7.04x.

- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2023 of 4.07x.


How does AJANTA PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AJANTA PHARMA 4,805.87.2834,980.1
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.92416,273.0
DIVIS LABORATORIES LTD9,360.018.87176,604.0
CIPLA LTD27,811.24.53125,993.0
TORRENT PHARMACEUTICALS LTD11,835.010.67126,316.0
DR REDDYS LABORATORIES LTD33,519.93.22107,795.0
MANKIND PHARMA LTD12,279.38.66106,278.0
ZYDUS LIFESCIENCES LTD23,241.54.31100,125.0
LUPIN LTD22,707.93.9990,623.2
AUROBINDO PHARMA LTD31,723.72.1267,198.8
ABBOTT INDIA LTD6,409.211.6774,773.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AJANTA PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.12x
Max industry PS 18.87x
Median industry PS 7.28x
Average industry PS 7.57x



You may also like the below Video Courses